Uniphar plc (LON:UPR - Get Free Report)'s share price reached a new 52-week high during mid-day trading on Friday . The stock traded as high as GBX 293.12 ($3.96) and last traded at GBX 286 ($3.86), with a volume of 14 shares. The stock had previously closed at GBX 290 ($3.92).
Analyst Ratings Changes
Separately, Shore Capital restated a "buy" rating on shares of Uniphar in a report on Tuesday, February 25th.
View Our Latest Stock Report on UPR
Uniphar Trading Up 1.7%
The company has a fifty day moving average price of GBX 247.21 and a 200-day moving average price of GBX 209.66. The company has a current ratio of 0.90, a quick ratio of 0.60 and a debt-to-equity ratio of 119.48. The firm has a market capitalization of £936.96 million, a price-to-earnings ratio of 20.93 and a beta of 0.75.
Uniphar Company Profile
(
Get Free Report)
Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.
Featured Articles
Before you consider Uniphar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Uniphar wasn't on the list.
While Uniphar currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
